Resatorvid

DB05943InvestigationalSmall molecule

Resatorvid is an investigational compound designed for the treatment of severe sepsis.

Mechanism: TAK-242 suppresses production of inflammatory mediators such as cytokine by inhibiting the signal transduction through Toll-like receptor 4 (TLR4) which is one of the receptors recognizing the bacterial components.
Curator reviewed
Primary indication: Investigated for use/treatment in sepsis and septicemia.Curator reviewed
Formula / weight: C₁₅H₁₇ClFNO₄S · 361.81 g/mol (avg)
Code names: TAK-242

Resolves to

Compound

Structure

InChIKeyLEEIJTHMHDMWLJ-CQSZACIVSA-NSMILES[H][C@]1(CCCC=C1C(=O)OCC)S(=O)(=O)NC1=C(Cl)C=C(F)C=C1

Targets

What you can answer from here — as of June 15, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Resatorvid, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.